You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Afamelanotide

Showing 1 - 23 of 23
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Variegate Porphyria Trial in Rotterdam (Afamelanotide 16 MG)

Recruiting
  • Variegate Porphyria
  • Afamelanotide 16 MG
  • Rotterdam, Netherlands
    CLINUVEL investigational site
May 3, 2023

Afamelanotide Evaluated as Skin DNA Repair Therapy in Healthy Volunteers Trial in Clinuvel Investigational Site (Afamelanotide)

Recruiting
  • Afamelanotide Evaluated as Skin DNA Repair Therapy in Healthy Volunteers
  • Afamelanotide
  • Clinuvel Investigational Site, United Kingdom
    CLINUVEL Investigational Site
Nov 9, 2022

Xeroderma Pigmentosum Trial in Clinuvel Investigational Site (Afamelanotide)

Recruiting
  • Xeroderma Pigmentosum
  • Afamelanotide
  • Clinuvel Investigational Site, Belgium
  • +1 more
Jan 19, 2023

Vitiligo Trial (Afamelanotide)

Not yet recruiting
  • Vitiligo
  • Afamelanotide
  • (no location specified)
May 26, 2022

Xeroderma Pigmentosum Trial in Regensburg (Afamelanotide)

Recruiting
  • Xeroderma Pigmentosum
  • Afamelanotide
  • Regensburg, Germany
    CLINUVEL investigative site
Jan 7, 2022

Acne Vulgaris Trial (Afamelanotide)

Completed
Has Results
  • Acne Vulgaris
  • Afamelanotide
  • (no location specified)
Sep 28, 2021

Arterial Ischemic Stroke Trial in Melbourne (Afamelanotide)

Completed
  • Arterial Ischemic Stroke
  • Afamelanotide
  • Melbourne, Australia
    The Alfred
Feb 22, 2022

Vitiligo Trial in Los Angeles (Afamelanotide and NB-UVB Light, NB-UVB Light)

Recruiting
  • Vitiligo
  • Afamelanotide and NB-UVB Light
  • NB-UVB Light
  • Los Angeles, California
    Clinuvel investigational site
Oct 25, 2023

Patients Undergoing Photodynamic Therapy Using Porfimer Sodium Trial (Afamelanotide, Placebo)

Completed
Has Results
  • Patients Undergoing Photodynamic Therapy Using Porfimer Sodium
  • Afamelanotide
  • Placebo
  • (no location specified)
Sep 7, 2021

Vitiligo Trial (Afamelanotide, Placebo)

Completed
Has Results
  • Vitiligo
  • Afamelanotide
  • Placebo
  • (no location specified)
Apr 29, 2021

Polymorphic Light Eruption Trial (Afamelanotide, Placebo)

Completed
Has Results
  • Polymorphic Light Eruption
  • Afamelanotide
  • Placebo
  • (no location specified)
Feb 25, 2021

Erythropoietic Protoporphyria Trial in Worldwide (Afamelanotide, Placebo)

Completed
Has Results
  • Erythropoietic Protoporphyria
  • Afamelanotide
  • Placebo
  • Helsinki, Finland
  • +7 more
Sep 16, 2021

Erythropoietic Protoporphyria Trial (Afamelanotide)

Completed
Has Results
  • Erythropoietic Protoporphyria
  • Afamelanotide
  • (no location specified)
Nov 2, 2020

Erythropoietic Protoporphyria Trial in United States (Afamelanotide, Placebo)

Completed
Has Results
  • Erythropoietic Protoporphyria
  • Afamelanotide
  • Placebo
  • Birmingham, Alabama
  • +5 more
Oct 7, 2019

Erythropoietic Protoporphyria Trial (Afamelanotide, Placebo)

Completed
Has Results
  • Erythropoietic Protoporphyria
  • Afamelanotide
  • Placebo
  • (no location specified)
Oct 8, 2019

Erythropoietic Protoporphyria Trial in United States (Afamelanotide, Placebo)

Completed
Has Results
  • Erythropoietic Protoporphyria
  • Afamelanotide
  • Placebo
  • Birmingham, Alabama
  • +6 more
Sep 6, 2019

Healthy Trial in Saint Paul (Afamelanotide Group 1, Afamelanotide Group 2)

Completed
  • Healthy
  • Afamelanotide Group 1
  • Afamelanotide Group 2
  • Saint Paul, Minnesota
    Prism Research Inc.
Aug 14, 2018

Melanocortin Receptor 4 Polymorphisms in GBM Treated With

Completed
  • Glioblastoma
    • Pisa, Italy
      Division of Radiotherapy, Department Of Oncology, University Hos
    Oct 24, 2017

    Vitiligo Trial (Afamelanotide, NB-UVB)

    Completed
    • Vitiligo
    • Afamelanotide
    • NB-UVB
    • (no location specified)
    Mar 21, 2013

    Vitiligo Trial in Detroit, New York (Afamelanotide, Narrow-Band UVB Light Treatment)

    Completed
    • Vitiligo
    • Afamelanotide
    • Narrow-Band UVB Light Treatment
    • Detroit, Michigan
    • +1 more
    Mar 21, 2013

    Phase III Trial of CUV1647 in Polymorphic Light Eruption (PLE)

    Completed
    • Polymorphic Light Eruption (PLE)
    • Afamelanotide (CUV1647)
    • Melbourne, Australia
    • +2 more
    Oct 4, 2011

    Actinic Keratoses, Carcinoma, Squamous Cell, Organ Transplant Recipients Trial in Worldwide (Afamelanotide (CUV1647), Placebo)

    Unknown status
    • Actinic Keratoses
    • +2 more
    • Afamelanotide (CUV1647)
    • Placebo
    • Brisbane, Queensland, Australia
    • +11 more
    Dec 3, 2010

    Solar Urticaria Trial in Manchester (afamelanotide)

    Completed
    • Solar Urticaria
    • afamelanotide
    • Manchester, United Kingdom
      Salford Royal Foundation Hospital (Hope Hospital)
    Sep 13, 2009